title: Paths to Alzheimer's disease prevention: from modifiable risk factors to biomarker enrichment strategies.
abstract: Alzheimer's disease (AD) represents an increasing worldwide healthcare epidemic. Secondary preventive disease-modifying treatments under clinical development are considered most effective when initiated as early as possible in the pathophysiological course and progression of the disease. Major targets are to enhance clearance and to reduce cerebral accumulation of amyloid, decrease hyperphosphorylation of tau and the generation of neurofibrillary tangles, reduce inflammation, and finally progressive neurodegeneration. Comprehensive sets of biological markers are needed to characterize the pathophysiological mechanisms, indicate effects of treatment and to facilitate early characterisation and detection of AD during the prodromal or even at asymptomatic stages. No primary or secondary preventive treatments for AD have been approved. Epidemiological research, however, has provided evidence of specifically modifiable risk and protective factors. Among them are vascular, lifestyle and psychological risk factors that may act both independently and by potentiating each other. These factors may be substantially impacted by single or multi-domain strategies to prevent or postpone the onset of AD-related pathophysiology. Researchers have recently started the European Dementia Prevention Initiative (EDPI), an international consortium to improve strategies for preventing dementia. EDPI, in particular, includes the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) which aims at optimizing the early identification of subjects at increased risk of late-life cognitive deterioration, and at the evaluation of multi-domain intervention strategies. The ongoing discussion on new diagnostic criteria provided by the International Working Group (IWG), as well as by the recommendations summoned by the National Institute on Aging and Alzheimer's Association (NIA-AA) initiative, has inspired the creation of novel study designs and the definition of earlier target populations for trials in pre- and asymptomatic at-risk and prodromal stages of AD. As a result, a number of promising international prevention trials are currently ongoing. In this review, we critically discuss the main paths to AD prevention through control of modifiable risk factors and lifestyle changes. We will also review the role of biomarkers to identify subgroups of patients who would most likely benefit from secondary prevention strategies, and to evaluate the benefit of treatment in such patients.
authors: S. Lista, Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) and Institut du Cerveau et de la Moelle épinière (ICM), Département de Neurologie, Hôpital de la Pitié-Salpétrière, Paris, France, slista@libero.it.
authors: S
authors: S
authors: Lista
authors: B
authors: B
authors: Dubois
authors: H
authors: H
authors: Hampel
mesh_terms: D000544:Alzheimer Disease / Q000175:diagnosis / Q000378:metabolism* / Q000517:prevention & control*; D015415:Biomarkers / Q000378:metabolism*; D018450:Disease Progression; D061345:Early Medical Intervention; D006801:Humans; D008019:Life Style; D062706:Prodromal Symptoms; D065840:Protective Factors; D012307:Risk Factors; D055502:Secondary Prevention
chemical_list: D015415:Biomarkers
references: PLoS One. 2010 Nov 15;5(11):e13950
references: 21085570
references: JAMA. 2009 Aug 12;302(6):638-48
references: 19671905
references: Neurodegener Dis. 2014;13(2-3):157-9
references: 23942061
references: Eur J Epidemiol. 2013 May;28(5):405-16
references: 23532744
references: Alzheimers Dement. 2014 Jan;10(1):115-31
references: 23850333
references: J Alzheimers Dis. 2011;25(4):679-94
references: 21483095
references: Alzheimers Res Ther. 2012 Feb 13;4(1):6
references: 22339927
references: Neurology. 2007 Mar 6;68(10):751-6
references: 17339582
references: Nat Rev Drug Discov. 2013 Apr;12(4):324
references: 23493086
references: J Alzheimers Dis. 2011;26 Suppl 3:321-9
references: 21971471
references: Alzheimers Dement. 2013 May;9(3):251-61
references: 23622690
references: Lancet. 2005 Dec 17;366(9503):2112-7
references: 16360788
references: Dement Geriatr Cogn Disord. 2010;30(3):277-84
references: 20847559
references: Med Clin North Am. 2013 May;97(3):399-424
references: 23642578
references: J Alzheimers Dis. 2013;33 Suppl 1:S329-47
references: 22735677
references: Biochem Pharmacol. 2014 Apr 15;88(4):661-70
references: 24418410
references: Biochem Pharmacol. 2014 Apr 15;88(4):426-49
references: 24275164
references: Arch Gen Psychiatry. 2012 Jan;69(1):98-106
references: 22213792
references: Nat Rev Neurosci. 2011 May;12(5):284-96
references: 21448224
references: Trends Neurosci. 2009 Feb;32(2):88-100
references: 19135729
references: Curr Alzheimer Res. 2011 Aug;8(5):520-42
references: 21605047
references: Clin Investig (Lond). 2012 Oct 1;2(10):975-984
references: 23139856
references: Expert Rev Mol Diagn. 2005 Sep;5(5):661-72
references: 16149870
references: Nature. 2012 Aug 2;488(7409):96-9
references: 22801501
references: J Alzheimers Dis. 2014;39(2):271-82
references: 24164735
references: Int J Geriatr Psychiatry. 2012 Dec;27(12):1218-38
references: 22396249
references: J Alzheimers Dis. 2011;23(2):177-93
references: 21098983
references: Arch Neurol. 2003 May;60(5):753-9
references: 12756140
references: Exp Neurol. 2010 Jun;223(2):334-46
references: 19815015
references: Aging Ment Health. 2013;17(2):133-46
references: 23171229
references: Arch Neurol. 2005 Oct;62(10):1556-60
references: 16216938
references: Rev Neurol (Paris). 2013 Oct;169(10):744-51
references: 24041475
references: Annu Rev Neurosci. 2011;34:185-204
references: 21456963
references: Lancet. 2011 Mar 19;377(9770):1019-31
references: 21371747
references: Biochem Pharmacol. 2014 Apr 15;88(4):560-4
references: 24269629
references: Alzheimers Dement. 2010 May;6(3):291-6
references: 20451879
references: Exp Gerontol. 2010 Jan;45(1):30-40
references: 19853650
references: Nat Rev Neurol. 2012 Nov 5;8(11):598-600
references: 23007701
references: Neuroradiology. 2012 Sep;54(9):929-38
references: 22246242
references: Am J Geriatr Psychiatry. 2011 May;19(5):471-81
references: 20808142
references: Alzheimers Dement. 2013 Nov;9(6):657-65
references: 23332672
references: J Am Geriatr Soc. 2012 Aug;60(8):1426-33
references: 22861348
references: Lancet Neurol. 2010 Jan;9(1):119-28
references: 20083042
references: Alzheimers Res Ther. 2013 Jun 25;5(3):31
references: 23795953
references: Nat Rev Neurol. 2010 Sep;6(9):508-17
references: 20717104
references: Neurobiol Aging. 2012 May;33(5):1007.e1-7
references: 22056199
references: Alzheimers Dement. 2014 May;10(3):381-92
references: 23850330
references: J Intern Med. 2014 Mar;275(3):229-50
references: 24605807
references: Prog Neurobiol. 2011 Dec;95(4):491-5
references: 21821094
references: Nat Rev Drug Discov. 2010 Jul;9(7):560-74
references: 20592748
references: Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):198-204
references: 19812459
references: Alzheimers Dement. 2010 Nov;6(6):456-64
references: 20434961
references: Nat Rev Neurol. 2010 Mar;6(3):131-44
references: 20157306
references: Epidemiol Rev. 2013;35:152-60
references: 23314404
references: Arch Neurol. 2011 Dec;68(12 ):1526-35
references: 21825215
references: Diabetes Care. 2013 Jul;36(7):2015-9
references: 23340883
references: Prog Neurobiol. 2011 Dec;95(4):501-4
references: 22005514
references: Expert Rev Mol Diagn. 2010 Jul;10(5):667-90
references: 20629514
references: Alzheimers Dement. 2013 Jul;9(4):438-44
references: 23809364
references: J Nutr Health Aging. 2013 Jan;17(1):54-63
references: 23299381
references: Alzheimers Dement. 2008 May;4(3):156-63
references: 18631960
references: Alzheimers Dement. 2013 Mar;9(2):123-131.e1
references: 23411394
references: Alzheimers Dement. 2012 Jul;8(4):337-42
references: 22748939
references: Hypertension. 2012 Apr;59(4):780-6
references: 22392902
references: J Clin Psychiatry. 2012 Dec;73(12 ):e1492-8
references: 23290333
references: Transl Psychiatry. 2013 Apr 09;3:e244
references: 23571809
references: Alzheimers Dement. 2013 Jan;9(1):63-75.e2
references: 23305823
references: Nat Genet. 2007 Jan;39(1):17-23
references: 17192785
references: J Neurol Sci. 2012 Nov 15;322(1-2):64-70
references: 22818266
references: Sci Transl Med. 2011 Nov 30;3(111):111cm33
references: 22133718
references: Prog Neurobiol. 2011 Dec;95(4):498-500
references: 21945642
references: Biochemistry. 2013 Jun 18;52(24):4107-26
references: 23721410
references: J Gerontol A Biol Sci Med Sci. 2010 Dec;65(12):1369-74
references: 20805238
references: Alzheimers Dement. 2009 Mar;5(2):114-21
references: 19328438
references: Arch Intern Med. 2011 Feb 28;171(4):333-9
references: 20975015
references: Alzheimers Dement. 2011 Jul;7(4):386-395.e6
references: 21784349
references: Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2):345-53
references: 22697066
references: Prog Mol Biol Transl Sci. 2012;107:79-100
references: 22482448
references: JAMA. 2009 Aug 12;302(6):627-37
references: 19671904
references: Dement Geriatr Cogn Disord. 2007;23(3):140-9
references: 17170526
references: Arch Gen Psychiatry. 2006 May;63(5):530-8
references: 16651510
references: Lancet Neurol. 2010 Jul;9(7):702-16
references: 20610346
references: Neuropsychopharmacology. 2014 Jan;39(1):189-201
references: 23799530
references: JAMA. 1997 Mar 12;277(10):793-9
references: 9052708
references: Prog Neurobiol. 2013 Feb-Mar;101-102:1-17
references: 22743552
references: Alzheimers Dement. 2010 May;6(3):230-8
references: 20451871
references: BMJ. 2001 Jun 16;322(7300):1447-51
references: 11408299
references: Lancet Neurol. 2005 Nov;4(11):705-11
references: 16239176
references: Alzheimers Dement. 2009 Mar;5(2):81-4
references: 19328433
references: Expert Rev Neurother. 2011 May;11(5):677-708
references: 21539488
references: Lancet Neurol. 2013 Feb;12(2):207-16
references: 23332364
references: Trends Neurosci. 2011 Aug;34(8):430-42
references: 21696834
references: N Engl J Med. 2012 Aug 30;367(9):795-804
references: 22784036
references: Alzheimers Dement. 2012 Jul;8(4):312-36
references: 22748938
references: Front Biosci (Elite Ed). 2012 Jan 01;4:169-80
references: 22201862
references: CNS Spectr. 2005 Nov;10(11 Suppl 18):6-9
references: 16273023
references: Neuroimaging Clin N Am. 2012 Feb;22(1):23-32,viii
references: 22284731